The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tabiasco, J.
Right arrow Articles by Fournié, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tabiasco, J.
Right arrow Articles by Fournié, J.-J.
The Journal of Immunology, 2003, 170: 5993-5998.
Copyright © 2003 by The American Association of Immunologists

Acquisition of Viral Receptor by NK Cells Through Immunological Synapse1

Julie Tabiasco*, Alain Vercellone*, Fabienne Meggetto*, Denis Hudrisier{dagger}, Pierre Brousset* and Jean-Jacques Fournié2,*

* Département Oncogénèse and Signalisation dans les Cellules Hématopoiétiques, {dagger} Département d’Immunologie, Center de Physiopathologie de Toulouse Purpan, Unité 563 de l’Institut National de la Santé et de la Recherche Médicale, BP3028 Centre Hospitalier Universitaire Purpan, Toulouse, France

Occasional EBV infection of human NK cells may lead to malignant diseases such as naso-pharyngeal NK lymphoma although NK cells do not express CD21, the primary receptor for EBV. Here we show that during early EBV infection in patients, NK cells attacked EBV-infected autologous B cells. In vitro, NK cells activated by conjugation to CD21+ B-EBV cell targets transiently acquired a weak CD21+ phenotype by synaptic transfer of few receptor molecules onto their own membrane. In the presence of viral particles, these ectopic receptors allowed EBV binding to the novel NK cell host. Hence, trans-synaptic acquisition of viral receptor from target cells might constitute an unsuspected mode of infection for otherwise unreachable lymphoid hosts.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Hudrisier, B. Clemenceau, S. Balor, S. Daubeuf, E. Magdeleine, M. Daeron, P. Bruhns, and H. Vie
Ligand Binding but Undetected Functional Response of FcR after Their Capture by T Cells via Trogocytosis
J. Immunol., November 15, 2009; 183(10): 6102 - 6113.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. I. Cohen, H. Kimura, S. Nakamura, Y.-H. Ko, and E. S. Jaffe
Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008
Ann. Onc., September 1, 2009; 20(9): 1472 - 1482.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. V. Beum, M. A. Lindorfer, and R. P. Taylor
Within Peripheral Blood Mononuclear Cells, Antibody-Dependent Cellular Cytotoxicity of Rituximab-Opsonized Daudi cells Is Promoted by NK Cells and Inhibited by Monocytes due to Shaving
J. Immunol., August 15, 2008; 181(4): 2916 - 2924.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. Roda-Navarro and H. T. Reyburn
Intercellular protein transfer at the NK cell immune synapse: mechanisms and physiological significance
FASEB J, June 1, 2007; 21(8): 1636 - 1646.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. E. McCann, P. Eissmann, B. Onfelt, R. Leung, and D. M. Davis
The Activating NKG2D Ligand MHC Class I-Related Chain A Transfers from Target Cells to NK Cells in a Manner That Allows Functional Consequences
J. Immunol., March 15, 2007; 178(6): 3418 - 3426.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Williams, J. J. Densmore, A. W. Pawluczkowycz, P. V. Beum, A. D. Kennedy, M. A. Lindorfer, S. H. Hamil, J. C. Eggleton, and R. P. Taylor
Thrice-Weekly Low-Dose Rituximab Decreases CD20 Loss via Shaving and Promotes Enhanced Targeting in Chronic Lymphocytic Leukemia
J. Immunol., November 15, 2006; 177(10): 7435 - 7443.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. A. Whale, H. L. Wilson, S. K. Tikoo, L. A. Babiuk, and P. J. Griebel
Passively acquired membrane proteins alter the functional capacity of bovine polymorphonuclear cells
J. Leukoc. Biol., September 1, 2006; 80(3): 481 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Bourbie-Vaudaine, N. Blanchard, C. Hivroz, and P.-H. Romeo
Dendritic Cells Can Turn CD4+ T Lymphocytes into Vascular Endothelial Growth Factor-Carrying Cells by Intercellular Neuropilin-1 Transfer
J. Immunol., August 1, 2006; 177(3): 1460 - 1469.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. V. Beum, A. D. Kennedy, M. E. Williams, M. A. Lindorfer, and R. P. Taylor
The Shaving Reaction: Rituximab/CD20 Complexes Are Removed from Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Cells by THP-1 Monocytes
J. Immunol., February 15, 2006; 176(4): 2600 - 2609.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
B. Onfelt, M. A. Purbhoo, S. Nedvetzki, S. Sowinski, and D. M. Davis
Long-Distance Calls Between Cells Connected by Tunneling Nanotubules
Sci. Signal., December 6, 2005; 2005(313): pe55 - pe55.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. Sprent
Swapping Molecules During Cell-Cell Interactions
Sci. Signal., March 1, 2005; 2005(273): pe8 - pe8.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Poupot, F. Pont, and J.-J. Fournie
Profiling Blood Lymphocyte Interactions with Cancer Cells Uncovers the Innate Reactivity of Human {gamma}{delta} T Cells to Anaplastic Large Cell Lymphoma
J. Immunol., February 1, 2005; 174(3): 1717 - 1722.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.